Dr. Bayan Al Share, MD
Hematology & Oncology (Hematology & Oncology Physician)
353 Fairmont Blvd
Rapid City, SD 57701
Who else practices at this address →
Pennington County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 15
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 292
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
SD license 12996 -
Student in an Organized Health Care Education/Training Program
MI license 4301110652
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Monument Health Rapid City Hospital Rapid City, SD
- Monument Health Spearfish Hospital Spearfish, SD
- Monument Health Custer Hospital Custer, SD
- Monument Health Lead-Deadwood Hospital Deadwood, SD
- Weston County Health Services Newcastle, WY
Medical groups
- Monument Health Rapid City Hospital Inc (564 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 292
- Services billed
- 2,044
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 398 | 131 |
| Established patient office or other outpatient visit, 30-39 minutes | 122 | 92 |
| New patient office or other outpatient visit, 60-74 minutes | 75 | 75 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 27 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Rapid City, SD | 184 |
| Prochlorperazine Maleate Other prescribers in Rapid City, SD | 143 |
| Xtandi (enzalutamide) | 101 |
| Dexamethasone Other prescribers in Rapid City, SD | 68 |
| Olanzapine Other prescribers in Rapid City, SD | 53 |
| Prednisone Other prescribers in Rapid City, SD | 46 |
| Eliquis (apixaban) Other prescribers in Rapid City, SD | 43 |
| Tamoxifen Citrate Other prescribers in Rapid City, SD | 33 |
| Lidocaine-Prilocaine (lidocaine/prilocaine) Other prescribers in Rapid City, SD | 29 |
| Letrozole Other prescribers in Rapid City, SD | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $20,000 in research payments for these studies, mostly to the institutions running them.
- The COMPASSHER2 trials comprehensive use of pathologic response assessment to optimize therapy in HER2POSITIVE breast cancer COMPASSHER2 residual disease rd a doubleblinded phase iii randomized trial of TDM1 compared …
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.